Analyst consensus rating
Aura Biosciences Analyst Rating: none
Direct answer
Aura Biosciences's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $16.60.
Forecast evidence checked October 18, 2026.
Get free Aura Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.10
- Average price target
- $16.60
- High price target
- $23.00
- Low price target
- $12.00
- Low target gap
- +96.7%
- Target upside
- +172.1%
- High target gap
- +277%
- Target range width
- 180.3%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Aura Biosciences?
Aura Biosciences has a verified none consensus. The same dataset has an average price target of $16.60.
How far are Aura Biosciences's low and high targets from the recorded price?
The low target implies +96.7%, while the high target implies +277%.
How many analysts are included in Aura Biosciences's consensus?
The verified consensus includes 5 analysts.
How is Aura Biosciences's target upside or downside calculated?
The average target of $16.60 is divided by the recorded price of $6.10, then one is subtracted to produce +172.1%. This does not guarantee a future return.
When was Aura Biosciences's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.